1.
Anesteziol Reanimatol
; (2): 25-30, 2004.
Article
in Russian
| MEDLINE
| ID: mdl-15206272
Subject(s)
Blood Loss, Surgical/prevention & control , Colloids/adverse effects , Hemophilia A/surgery , Hemostasis/drug effects , Plasma Substitutes/adverse effects , Thrombocytopenia/surgery , Adolescent , Adult , Blood Coagulation Factors/analysis , Blood Coagulation Tests , Colloids/therapeutic use , Dextrans/adverse effects , Dextrans/therapeutic use , Gelatin/adverse effects , Gelatin/therapeutic use , Hemophilia A/blood , Humans , Hydroxyethyl Starch Derivatives/adverse effects , Hydroxyethyl Starch Derivatives/therapeutic use , Plasma Substitutes/therapeutic use , Platelet Aggregation/drug effects , Prospective Studies , Succinates/adverse effects , Succinates/therapeutic use , Thrombocytopenia/blood , Treatment Outcome
2.
Ter Arkh
; 73(7): 34-40, 2001.
Article
in Russian
| MEDLINE
| ID: mdl-11523406
ABSTRACT
AIM: To compare the capacity of ionophore for calcium ions and growth factors (granulocytic-macrophagal colony-stimulating factor, interleukin-4, tumor necrosis factor) to induce costimulatory molecules on the surface of blast cells from patients with acute myeloid leukemia (AML). MATERIALS AND METHODS: The study was carried out in 6 patients with primary and resistant AML using culturing and flow cytometry. RESULTS: Blast cells obtained from patients during diagnosis of AML and after drug therapy of resistant AML acquire the dendrite phenotype under the effects of growth factors and Ca ion ionophore. CONCLUSION: Calcium metabolism modulators can be used for creation of antileukemic vaccines.
